| __timestamp | Cytokinetics, Incorporated | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 675200000 |
| Thursday, January 1, 2015 | 19667000 | 771800000 |
| Friday, January 1, 2016 | 27823000 | 1205500000 |
| Sunday, January 1, 2017 | 36468000 | 1146500000 |
| Monday, January 1, 2018 | 31282000 | 1125800000 |
| Tuesday, January 1, 2019 | 39610000 | 1166100000 |
| Wednesday, January 1, 2020 | 52820000 | 1175500000 |
| Friday, January 1, 2021 | 96803000 | 1111400000 |
| Saturday, January 1, 2022 | 177977000 | 1210100000 |
| Sunday, January 1, 2023 | 173612000 | 1274600000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical and biotechnology sectors, understanding financial health is crucial. This chart compares the Selling, General, and Administrative (SG&A) expenses of Cytokinetics, Incorporated and Perrigo Company plc from 2014 to 2023. Over this period, Perrigo consistently outspent Cytokinetics, with its SG&A expenses peaking at approximately $1.27 billion in 2023, a 90% increase from 2014. In contrast, Cytokinetics saw a more dramatic rise, with expenses growing tenfold, reaching around $178 million in 2022. This stark difference highlights Perrigo's established market presence and Cytokinetics' rapid growth trajectory. Such insights are invaluable for investors and analysts seeking to understand the strategic priorities and operational scales of these companies. As the industry evolves, tracking these financial metrics will be key to predicting future market dynamics.
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Breaking Down SG&A Expenses: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited
Perrigo Company plc or MiMedx Group, Inc.: Who Manages SG&A Costs Better?